Autoimmune hepatitis in Brazil: An overview

Scandinavian Journal of Immunology

Volumn 66, Issue 2-3, 2007, Pages 208-216

  Goldberg, A C ^a,b,d   Bittencourt, P L ^c   Oliveira, L C ^b   Ramasawmy, R ^b   Marin, M L C ^b   Palacios, S A ^b   Kalil, J ^b,d   Porta, G ^b  

^a University of São Paulo ^*  (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Hospital Portugues   (Brazil)

^d Millenium Institutes   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN ANTIBODY; AMINO ACID; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DR5 ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 13; INTERLEUKIN 4; NEUTROPHIL CYTOPLASMIC ANTIBODY;

AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; BRAZIL; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; LIVER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

BRAZIL; HEPATITIS, AUTOIMMUNE; HUMANS;

EID: 34447317587     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.01967.x     Document Type: Review

References (91)

1. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006 354 : 54 66.
2. Czaja AJ. Autoimmune hepatitis. Evolving concepts and treatment strategies. Dig Dis Sci 1995 40 : 435 56.
3. Czaja AJ, Souto EO, Bittencourt PL et al. Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. J Hepatol 2002 37 : 302 8.
4. Porta G. Autoimmune hepatitis. J Pediatr (Rio J) 2000 76 (Suppl. 1 S181 6.
5. Gregorio GV, Portmann B, Reid F et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997 25 : 541 7.
6. Bittencourt PL, Goldberg AC, Cancado EL, Porta G, Laudanna AA, Kalil J. Different HLA profiles confer susceptibility to autoimmune hepatitis type 1 and 2. Am J Gastroenterol 1998 93 : 1394 5.
7. Bittencourt PL, Goldberg AC, Cancado EL et al. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am J Gastroenterol 1999 94 : 1906 13.
8. Fainboim L, Marcos Y, Pando M et al. Chronic active autoimmune hepatitis in children. Strong association with a particular HLA-DR6 (DRB1*1301) haplotype. Hum Immunol 1994 41 : 146 50.
9. Manns MP, Kruger M. Immunogenetics of chronic liver diseases. Gastroenterology 1994 106 : 1676 97.
10. Bittencourt PL, Farias AQ, Porta P et al. Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender and genetic background. J Clin Gastroenterol 2007, in press.
11. Verma S, Gunuwan B, Mendler M, Govindrajan S, Redeker A. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy. Am J Gastroenterol 2004 99 : 1510 6.
12. Vogel A, Heinrich E, Bahr MJ et al. Long-term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant 2004 18 : 62 9.
13. Porta G, Schneidwind KDR, Ribeiro CMF et al. Autoimmune hepatitis type 1 in children is associated to high ige levels (Abstract). J Pediatr Gastroenterol Nutr 2004 39 (Suppl. 1 S185.
14. Manns MP, Strassburg CP. Autoimmune hepatitis: clinical challenges. Gastroenterology 2001 120 : 1502 17.
15. Skoog SM, Rivard RE, Batts KP, Smith CI. Autoimmune hepatitis preceded by acute hepatitis A infection. Am J Gastroenterol 2002 97 : 1568 9.
16. Fainboim L, Canero Velasco MC, Marcos CY et al. Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB*1301, a marker for pediatric autoimmune hepatitis. Hepatology 2001 33 : 1512 7.
17. Alvarez F, Berg PA, Bianchi FB et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999 31 : 929 38.
18. Krawitt EL. Autoimmune hepatitis: classification, heterogeneity, and treatment. Am J Med 1994 96 : 23S 6S.
19. Lidman K, Biberfeld G, Fagraeus A et al. Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis. Clin Exp Immunol 1976 24 : 266 72.
20. Gabbiani G, Ryan GB, Lamelin JP et al. Human smooth muscle autoantibody. Its identification as antiactin antibody and a study of its binding to "nonmuscular" cells. Am J Pathol 1973 72 : 473 88.
21. Cancado EL, Vilas-Boas LS, Abrantes-Lemos CP et al. Heat serum inactivation as a mandatory procedure for antiactin antibody detection in cell culture. Hepatology 1996 23 : 1098 104.
22. Pellicano R, Touscoz GA, Smedile A et al. Prevalence of non-organ-specific autoantibodies in patients suffering from duodenal ulcer with and without Helicobacter pylori infection. Dig Dis Sci 2004 49 : 395 8.
23. Zamanou A, Samiotaki M, Panayotou G, Margaritis L, Lymberi P. Fine specificity and subclasses of IgG anti-actin autoantibodies differ in health and disease. J Autoimmun 2003 20 : 333 44.
24. LaRusso NF, Shneider BL, Black D et al. Primary sclerosing cholangitis: summary of a workshop. Hepatology 2006 44 : 746 64.
25. Takaya M, Kawahara S, Namba T, Grob D. Antibodies against myofibrillar proteins in myasthenia gravis patients. Tokai J Exp Clin Med 1992 17 : 35 9.
26. Manns MP, Vogel A. Autoimmune hepatitis, from mechanisms to therapy. Hepatology 2006 43 : S132 44.
27. Avrameas S, Guilbert B, Mahana W, Matsiota P, Ternynck T. Recognition of self and non-self constituents by polyspecific autoreceptors. Int Rev Immunol 1988 3 : 1 15.
28. Manns MP, Johnson EF, Griffin KJ, Tan EM, Sullivan KF. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest 1989 83 : 1066 72.
29. Homberg JC, Abuaf N, Bernard O et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology 1987 7 : 1333 9.
30. Lapierre P, Hajoui O, Homberg JC, Alvarez F. Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology 1999 116 : 643 9.
31. Lohr H, Treichel U, Poralla T, Manns M, Meyer zum Buschenfelde KH, Fleischer B. The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis. Hepatology 1990 12 : 1314 20.
32. Czaja AJ, Shums Z, Norman GL. Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitis. Autoimmunity 2002 35 : 475 83.
33. Cantor HM, Dumont AE. Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature 1967 215 : 744 5.
34. Knolle PA, Limmer A. Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells. Trends Immunol 2001 22 : 432 7.
35. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology 2006 43 : S54 62.
36. Mackay IR. Hepatoimmunology: a perspective. Immunol Cell Biol 2002 80 : 36 44.
37. O'Connell PJ, Li W, Wang Z, Specht SM, Logar AJ, Thomson AW. Immature and mature CD8alpha+ dendritic cells prolong the survival of vascularized heart allografts. J Immunol 2002 168 : 143 54.
38. Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003 3 : 51 62.
39. Klugewitz K, Blumenthal-Barby F, Schrage A, Knolle PA, Hamann A, Crispe IN. Immunomodulatory effects of the liver: deletion of activated CD4+ effector cells and suppression of IFN-gamma-producing cells after intravenous protein immunization. J Immunol 2002 169 : 2407 13.
40. Liu ZX, Govindarajan S, Okamoto S, Dennert G. Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver. J Immunol 2001 166 : 3035 41.
41. Onoe T, Ohdan H, Tokita D et al. Liver sinusoidal endothelial cells tolerize T cells across MHC barriers in mice. J Immunol 2005 175 : 139 46.
42. Lalor PF, Shields P, Grant A, Adams DH. Recruitment of lymphocytes to the human liver. Immunol Cell Biol 2002 80 : 52 64.
43. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007 25 : 297 336.
44. Limmer A, Ohl J, Kurts C et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 2000 6 : 1348 54.
45. Watanabe T, Katsukura H, Shirai Y et al. A liver tolerates a portal antigen by generating CD11c+ cells, which select Fas ligand+ Th2 cells via apoptosis. Hepatology 2003 38 : 403 12.
46. Lau AH, Thomson AW. Dendritic cells and immune regulation in the liver. Gut 2003 52 : 307 14.
47. Knolle PA, Germann T, Treichel U et al. Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells. J Immunol 1999 162 : 1401 7.
48. Muschen M, Warskulat U, Douillard P, Gilbert E, Haussinger D. Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells. Hepatology 1998 27 : 200 8.
49. Punnonen J, Aversa G, Cocks BG et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A 1993 90 : 3730 4.
50. de Vries JE, Punnonen J, Cocks BG, de Waal Malefyt R, Aversa G. Regulation of the human IgE response by IL4 and IL13. Res Immunol 1993 144 : 597 601.
51. Fiore G, Galetta V, Piazzolla G et al. CD45RA and CD45RO isoform expression on intrahepatic T-lymphocytes in chronic hepatitis C. Microbios 1997 92 : 73 82.
52. Sansonno D, Lauletta G, De Re V et al. Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection. Eur J Immunol 2004 34 : 126 36.
53. Dalekos GN, Obermayer-Straub P, Bartels M et al. Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infection. J Hepatol 2003 39 : 800 6.
54. Rigopoulou EI, Mytilinaiou M, Romanidou O, Liaskos C, Dalekos GN. Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis. J Autoimmune Dis 2007 4 : 2.
55. de Biasio MB, Periolo N, Avagnina A et al. Liver infiltrating mononuclear cells in children with type 1 autoimmune hepatitis. J Clin Pathol 2006 59 : 417 23.
56. Hashimoto E, Lindor KD, Homburger HA et al. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc 1993 68 : 1049 55.
57. Song E, Lee SK, Wang J et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003 9 : 347 51.
58. Hodgson HJ, Wands JR, Isselbacher KJ. Alteration in suppressor cell activity in chronic active hepatitis. Proc Natl Acad Sci U S A 1978 75 : 1549 53.
59. Longhi MS, Ma Y, Mitry RR et al. Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun 2005 25 : 63 71.
60. Longhi MS, Hussain MJ, Mitry RR et al. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 2006 176 : 4484 91.
61. Lohr HF, Pingel S, Weyer S, Fritz T, Galle PR. Individual and common antigen-recognition sites of liver-derived T cells in patients with autoimmune hepatitis. Scand J Immunol 2003 57 : 384 90.
62. Doherty DG, Donaldson PT, Underhill JA et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 1994 19 : 609 15.
63. Czaja AJ, Strettell MD, Thomson LJ et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology 1997 25 : 317 23.
64. Seki T, Ota M, Furuta S et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology 1992 103 : 1041 7.
65. Manns M, Scheucher S, Jentzsch M et al. Genetics in autoimmune hepatitis type 2 [abstr]. Hepatology 1991 14 : 60.
66. Vazquez-Garcia MN, Alaez C, Olivo A et al. MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis. J Hepatol 1998 28 : 985 90.
67. de Mello AL, Ferreira EC, Vilas Boas LS, Pannuti CS. Cytomegalovirus infection in a day-care center in the municipality of Sao Paulo. Rev Inst Med Trop Sao Paulo 1996 38 : 165 9.
68. Vitral CL, Gaspar AM, Souto FJ. Epidemiological pattern and mortality rates for hepatitis A in Brazil, 1980-2002 - a review. Mem Inst Oswaldo Cruz 2006 101 : 119 27.
69. Goldberg AC, Bittencourt PL, Mougin B et al. Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus. Hum Immunol 2001 62 : 165 9.
70. Strettell MD, Donaldson PT, Thomson LJ et al. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology 1997 112 : 2028 35.
71. Donaldson PT, Czaja AJ. Genetic effects on susceptibility, clinical expression, and treatment outcome of type 1 autoimmune hepatitis. Clin Liver Dis 2002 6 : 707 25.
72. Pando M, Larriba J, Fernandez GC et al. Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition. Hepatology 1999 30 : 1374 80.
73. Honda M, Kawai H, Shirota Y, Yamashita T, Takamura T, Kaneko S. cDNA microarray analysis of autoimmune hepatitis, primary biliary cirrhosis and consecutive disease manifestation. J Autoimmun 2005 25 : 133 40.
74. Cançado ELR, Porta G. Autoimmune hepatitis in South America. In : Manns MP, Paumgartner G, Leuschner U, eds Immunology and the Liver, Falk symposium 114, Dordrecht : Kluwer Academic Publishers and Falk Foundation, 2000 : 82 92.
75. Goldberg AC, Chiarella JM, Marin MLC et al. Molecular typing of HLA class II antigens in the São Paulo population. Genet Mol Biol 1998 21 : 301 5.
76. Czaja AJ, Cookson S, Constantini PK, Clare M, Underhill JA, Donaldson PT. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology 1999 117 : 645 52.
77. Cookson S, Constantini PK, Clare M et al. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology 1999 30 : 851 6.
78. Bittencourt PL, Palacios SA, Cancado EL et al. Autoimmune hepatitis in Brazilian patients is not linked to tumor necrosis factor alpha polymorphisms at position -308. J Hepatol 2001 35 : 24 8.
79. Djilali-Saiah I, Fakhfakh A, Louafi H, Caillat-Zucman S, Debray D, Alvarez F. HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis. J Hepatol 2006 45 : 844 50.
80. Barnes R, Grabs R, Polychronakos C. A CTLA4 polymorphism affects lymphocyte mRNA levels but is not associated with type-1 diabetes in a Canadian dataset. Diabetologia 1997 40 : 194.
81. Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2001 2 : 145 52.
82. Agarwal K, Czaja AJ, Jones DE, Donaldson PT. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 2000 31 : 49 53.
83. Bittencourt PL, Palacios SA, Cancado EL et al. Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil. Am J Gastroenterol 2003 98 : 1616 20.
84. Harada M, Magara-Koyanagi K, Watarai H et al. IL-21-induced Bepsilon cell apoptosis mediated by natural killer T cells suppresses IgE responses. J Exp Med 2006 203 : 2929 37.
85. Trinchieri G. Proinflammatory and immunoregulatory functions of interleukin-12. Int Rev Immunol 1998 16 : 365 96.
86. Oettgen HC. Regulation of the IgE isotype switch: new insights on cytokine signals and the functions of epsilon germline transcripts. Curr Opin Immunol 2000 12 : 618 23.
87. Jeannin P, Lecoanet S, Delneste Y, Gauchat JF, Bonnefoy JY. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol 1998 160 : 3555 61.
88. Punnonen J, de Waal Malefyt R, van Vlasselaer P, Gauchat JF, de Vries JE. IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J Immunol 1993 151 : 1280 9.
89. Chernavsky AC, Paladino N, Rubio AE et al. Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children. Hum Immunol 2004 65 : 683 91.
90. Liu X, Beaty TH, Deindl P et al. Associations between total serum IgE levels and the 6 potentially functional variants within the genes IL4, IL13, and IL4RA in German children: the German multicenter atopy study. J Allergy Clin Immunol 2003 112 : 382 8.
91. Heinzmann A, Mao XQ, Akaiwa M et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet 2000 9 : 549 59.